# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA1175373 | F | Cytotoxicity against human OS-RC2 cells by MTT assay | Homo sapiens | 21 | ALA1177786 | cell-based format | Scientific Literature | |
2. | ALA1285636 | F | Cytotoxicity against human OS-RC2 cells by MTT assay | Homo sapiens | 19 | ALA1275322 | cell-based format | Scientific Literature | |
3. | ALA1285695 | F | Cytotoxicity against human OS-RC2 cells by MTT assay | Homo sapiens | 15 | ALA1275266 | cell-based format | Scientific Literature | |
4. | ALA1671306 | F | Cytotoxicity against human OS-RC2 cells by MTT assay | Homo sapiens | 8 | ALA1667727 | cell-based format | Scientific Literature | |
5. | ALA1787574 | F | Antiproliferative activity against human OS-RC2 cells after 72 hrs by MTT assay | Homo sapiens | 10 | ALA1782036 | cell-based format | Scientific Literature | |
6. | ALA1832092 | F | Cytotoxicity against human OS-RC2 cells by MTT assay | Homo sapiens | 26 | ALA1828501 | cell-based format | Scientific Literature | |
7. | ALA2321032 | F | Cytotoxicity against human OS-RC2 cells by MTT assay | Homo sapiens | 52 | ALA2311271 | cell-based format | Scientific Literature | |
8. | ALA2353160 | F | Cytotoxicity against human OS-RC2 cells after 72 hrs by MTT assay | Homo sapiens | 14 | ALA2346613 | cell-based format | Scientific Literature | |
9. | ALA2363575 | F | SANGER: Inhibition of human OS-RC-2 cell growth in a cell viability assay. | Homo sapiens | 137 | ALA1201861 | cell-based format | Sanger Institute Genomics of Drug Sensitivity in Cancer | |
10. | ALA4049580 | F | Antitumor activity against human OS-RC2 cells xenografted in nude mouse assessed as tumor weight at 6 mg/kg administered three times a week through oral gavage measured after 32 days (Rvb = 0.68 +/- 0.06 g) | Homo sapiens | 1 | ALA4049384 | organism-based format | Scientific Literature | |
11. | ALA4049581 | F | Antitumor activity against human OS-RC2 cells xenografted in nude mouse assessed as tumor weight at 1.5 mg/kg, iv administered three times a week measured after 32 days (Rvb = 0.68 +/- 0.06 g) | Homo sapiens | 1 | ALA4049384 | organism-based format | Scientific Literature | |
12. | ALA4049582 | F | Antitumor activity against human OS-RC2 cells xenografted in nude mouse assessed as tumor weight at 24 mg/kg, iv administered once weekly measured after 32 days (Rvb = 0.68 +/- 0.06 g) | Homo sapiens | 1 | ALA4049384 | organism-based format | Scientific Literature | |
13. | ALA4049583 | F | Antitumor activity against human OS-RC2 cells xenografted in nude mouse assessed as tumor growth inhibition at 6 mg/kg administered three times a week through oral gavage measured after 32 days relative to control | Homo sapiens | 1 | ALA4049384 | organism-based format | Scientific Literature | |
14. | ALA4049584 | F | Antitumor activity against human OS-RC2 cells xenografted in nude mouse assessed as tumor growth inhibition at 1.5 mg/kg, iv administered three times a week measured after 32 days relative to control | Homo sapiens | 1 | ALA4049384 | organism-based format | Scientific Literature | |
15. | ALA4049585 | F | Antitumor activity against human OS-RC2 cells xenografted in nude mouse assessed as tumor growth inhibition at 24 mg/kg, iv administered once weekly measured after 32 days relative to control | Homo sapiens | 1 | ALA4049384 | organism-based format | Scientific Literature | |
16. | ALA4049621 | F | Antitumor activity against human OS-RC2 cells xenografted in nude mouse assessed as tumor volume at 6 mg/kg administered three times a week through oral gavage measured on day 1 (Rvb = 167.51 +/- 17.09 mm3) | Homo sapiens | 1 | ALA4049384 | organism-based format | Scientific Literature | |
17. | ALA4049622 | F | Antitumor activity against human OS-RC2 cells xenografted in nude mouse assessed as reduction in tumor volume at 6 mg/kg administered three times a week through oral gavage measured on day 5 relative to control | Homo sapiens | 1 | ALA4049384 | organism-based format | Scientific Literature | |
18. | ALA4049623 | F | Antitumor activity against human OS-RC2 cells xenografted in nude mouse assessed as reduction in tumor volume at 6 mg/kg administered three times a week through oral gavage measured on day 8 relative to control | Homo sapiens | 1 | ALA4049384 | organism-based format | Scientific Literature | |
19. | ALA4049624 | F | Antitumor activity against human OS-RC2 cells xenografted in nude mouse assessed as reduction in tumor volume at 6 mg/kg administered three times a week through oral gavage measured on day 12 relative to control | Homo sapiens | 1 | ALA4049384 | organism-based format | Scientific Literature | |
20. | ALA4049625 | F | Antitumor activity against human OS-RC2 cells xenografted in nude mouse assessed as reduction in tumor volume at 6 mg/kg administered three times a week through oral gavage measured on day 15 relative to control | Homo sapiens | 1 | ALA4049384 | organism-based format | Scientific Literature |